{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:53:10Z","timestamp":1793400790021,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To examine the potential utility of five multifocal pupillographic objective perimetry (mfPOP) protocols, in the assessment of early diabetic retinopathy (DR) and generalised diabetes-related tissue injury in subjects with type 1 diabetes (T1D).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Twenty-five T1D subjects (age 41.8\u2009\u00b1\u200912.1 (SD) years, 13 male) with either no DR (<jats:italic>n<\/jats:italic>\u2009=\u200913) or non-proliferative DR (<jats:italic>n<\/jats:italic>\u2009=\u200912), and 23 age and gender-matched control subjects (age 39.7\u2009\u00b1\u200912.9\u2009years, 9 male) were examined by mfPOP using five different stimulus methods differing in visual field eccentricity (central 30\u00b0 and 60\u00b0), and colour (blue, yellow or green test-stimuli presented on, respectively, a blue, yellow or red background), each assessing 44 test-locations per eye. In the T1D subjects, we assessed 16 metabolic status and diabetes complications variables. These were summarised as three principal component analysis (PCA) factors. DR severity was assessed using Early Treatment of Diabetic Retinopathy Study (ETDRS) scores. Area under the curve (AUC) from receiver operator characteristic analyses quantified the diagnostic power of mfPOP response sensitivity and delay deviations for differentiating: (i) T1D subjects from control subjects, (ii) T1D subjects according to three levels of the identified PCA-factors from control subjects, and (iii) TID subjects with from those without non-proliferative DR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The two largest PCA-factors describing the T1D subjects were associated with metabolic variables (e.g. body mass index, HbA1c), and tissue-injury variables (e.g. serum creatinine, vibration perception). Linear models showed that mfPOP per-region response delays were more strongly associated than sensitivities with the metabolic PCA-factor and ETDRS scores. Combined mfPOP amplitude and delay measures produced AUCs of 90.4\u2009\u00b1\u20098.9% (mean\u2009\u00b1\u2009SE) for discriminating T1D subjects with DR from control subjects, and T1D subjects with DR from those without of 85.9\u2009\u00b1\u20098.8%. The yellow and green stimuli performed better than blue on most measures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions\/interpretation<\/jats:title>\n                <jats:p>In T1D subjects, mfPOP testing was able to identify localised visual field functional abnormalities (retinal\/neural reflex) in the absence or presence of mild DR. mfPOP responses were also associated with T1D metabolic status, but less so with early stages of non-ophthalmic diabetes complications.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-022-02382-2","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T12:07:10Z","timestamp":1649851630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Multifocal pupillographic objective perimetry for assessment of early diabetic retinopathy and generalised diabetes-related tissue injury in persons with type 1 diabetes"],"prefix":"10.1186","volume":"22","author":[{"given":"Faran","family":"Sabeti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne F.","family":"Carle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia J.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin E.","family":"Coombes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melody","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Maddess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"issue":"14","key":"2382_CR1","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","unstructured":"The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977\u201386.","journal-title":"N Engl J Med"},{"issue":"1","key":"2382_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/dc13-2112","volume":"37","author":"DM Nathan","year":"2014","unstructured":"Nathan DM, Group DER. The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014;37(1):9\u201316.","journal-title":"Diabetes Care"},{"issue":"11","key":"2382_CR3","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.ophtha.2008.08.023","volume":"115","author":"R Klein","year":"2008","unstructured":"Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin epidemiologic study of diabetic retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115(11):1859\u201368.","journal-title":"Ophthalmology"},{"issue":"10","key":"2382_CR4","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/dc10-1303","volume":"33","author":"S Tesfaye","year":"2010","unstructured":"Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285\u201393.","journal-title":"Diabetes Care"},{"issue":"6","key":"2382_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.survophthal.2010.02.005","volume":"55","author":"S Sivaprasad","year":"2010","unstructured":"Sivaprasad S, Elagouz M, McHugh D, Shona O, Dorin G. Micropulsed diode laser therapy: evolution and clinical applications. Surv Ophthalmol. 2010;55(6):516\u201330.","journal-title":"Surv Ophthalmol"},{"issue":"12","key":"2382_CR6","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1001\/jama.293.12.1509","volume":"293","author":"P van Wijngaarden","year":"2005","unstructured":"van Wijngaarden P, Coster DJ, Williams KA. Inhibitors of ocular neovascularization: promises and potential problems. JAMA. 2005;293(12):1509\u201313.","journal-title":"JAMA"},{"issue":"9735","key":"2382_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124\u201336.","journal-title":"Lancet"},{"key":"2382_CR8","doi-asserted-by":"crossref","unstructured":"Tan GS, Cheung N, Simo R, Cheung GC, Wong TY. Diabetic macular oedema. Lancet Diabetes Endocrinol. 2017;5:143\u201355.","DOI":"10.1016\/S2213-8587(16)30052-3"},{"issue":"9647","key":"2382_CR9","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/S0140-6736(08)61412-9","volume":"372","author":"N Chaturvedi","year":"2008","unstructured":"Chaturvedi N, Porta M, Klein R, et al. Effect of candesartan on prevention (DIRECT-prevent 1) and progression (DIRECT-protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. Lancet. 2008;372(9647):1394\u2013402.","journal-title":"Lancet"},{"issue":"3","key":"2382_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1001288","volume":"363","author":"EY Chew","year":"2010","unstructured":"Accord Eye Study Group, Chew EY, Ambrosius WT, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010;363(3):233\u201344.","journal-title":"N Engl J Med"},{"issue":"9600","key":"2382_CR11","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(07)61607-9","volume":"370","author":"AC Keech","year":"2007","unstructured":"Keech AC, Mitchell P, Summanen PA, et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet. 2007;370(9600):1687\u201397.","journal-title":"Lancet"},{"issue":"7","key":"2382_CR12","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00417-013-2273-z","volume":"251","author":"F Sabeti","year":"2013","unstructured":"Sabeti F, James AC, Essex RW, Maddess T. Multifocal pupillography identifies retinal dysfunction in early age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2013;251(7):1707\u201316.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"2382_CR13","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/OPX.0000000000000319","volume":"91","author":"F Sabeti","year":"2014","unstructured":"Sabeti F, Maddess T, Essex RW, et al. Multifocal pupillography in early age-related macular degeneration. Optom Vis Sci. 2014;91(8):904\u201315.","journal-title":"Optom Vis Sci"},{"issue":"12","key":"2382_CR14","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1097\/OPX.0b013e318235af61","volume":"88","author":"F Sabeti","year":"2011","unstructured":"Sabeti F, Maddess T, Essex RW, James AC. Multifocal pupillographic assessment of age-related macular degeneration. Optom Vis Sci. 2011;88(12):1477\u201385.","journal-title":"Optom Vis Sci"},{"issue":"1","key":"2382_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1167\/iovs.11-8004","volume":"53","author":"F Sabeti","year":"2012","unstructured":"Sabeti F, Maddess T, Essex RW, James AC. Multifocal pupillography identifies ranibizumab-induced changes in retinal function for exudative age-related macular degeneration. Invest Ophthalmol Vis Sci. 2012;53(1):253\u201360.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2382_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.visres.2012.07.019","volume":"69","author":"Y Rosli","year":"2012","unstructured":"Rosli Y, Bedford SM, James AC, Maddess T. Photopic and scotopic multifocal pupillographic responses in age-related macular degeneration. Vis Res. 2012;69:42\u20138.","journal-title":"Vis Res"},{"issue":"1","key":"2382_CR17","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1167\/iovs.09-3659","volume":"51","author":"A Bell","year":"2010","unstructured":"Bell A, James AC, Kolic M, Essex RW, Maddess T. Dichoptic multifocal pupillography reveals afferent visual field defects in early type 2 diabetes. Invest Ophthalmol Vis Sci. 2010;51(1):602\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"2382_CR18","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1167\/iovs.15-16712","volume":"56","author":"F Sabeti","year":"2015","unstructured":"Sabeti F, Nolan CJ, James AC, Jenkins A, Maddess T. Multifocal pupillography identifies changes in visual sensitivity according to severity of diabetic retinopathy in type 2 diabetes. Invest Ophthalmol Vis Sci. 2015;56(8):4504\u201313.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13(32)","key":"2382_CR19","first-page":"1","volume":"10","author":"BB Rai","year":"2021","unstructured":"Rai BB, Maddess T, Carle CF, et al. Comparing objective perimetry, matrix perimetry, and regional retinal thickness in early diabetic macular oedema. Trans Vis Sci Tech. 2021;10(13(32)):1\u201312.","journal-title":"Trans Vis Sci Tech"},{"key":"2382_CR20","doi-asserted-by":"publisher","first-page":"45847","DOI":"10.1038\/srep45847","volume":"7","author":"F Sabeti","year":"2017","unstructured":"Sabeti F, James AC, Carle CF, et al. Comparing multifocal pupillographic objective perimetry (mfPOP) and multifocal visual evoked potentials (mfVEP) in retinal diseases. Sci Rep. 2017;7:45847.","journal-title":"Sci Rep"},{"issue":"9","key":"2382_CR21","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/ceo.12346","volume":"42","author":"CF Carle","year":"2014","unstructured":"Carle CF, James AC, Kolic M, Essex RW, Maddess T. Luminance and colour variant pupil perimetry in glaucoma. Clin Exp Ophthalmol. 2014;42(9):815\u201324.","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"2382_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1167\/iovs.12-10829","volume":"54","author":"CF Carle","year":"2013","unstructured":"Carle CF, James AC, Maddess T. The pupillary response to color and luminance variant multifocal stimuli. Invest Ophthalmol Vis Sci. 2013;54(1):467\u201375.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5 Suppl","key":"2382_CR23","first-page":"823","volume":"98","author":"Early treatment diabetic retinopathy study research group","year":"1991","unstructured":"Early treatment diabetic retinopathy study research group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology. 1991;98(5 Suppl):823\u201333.","journal-title":"Ophthalmology"},{"issue":"5 Suppl","key":"2382_CR24","first-page":"766","volume":"98","author":"Early photocoagulation for diabetic retinopathy","year":"1991","unstructured":"Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early treatment diabetic retinopathy study research group. Ophthalmology. 1991;98(5 Suppl):766\u201385.","journal-title":"Ophthalmology"},{"key":"2382_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.visres.2014.12.023","volume":"108","author":"JW Seamons","year":"2015","unstructured":"Seamons JW, Barbosa MS, Bubna-Litic A, Maddess T. A lower bound on the number of mechanisms for discriminating fourth and higher order spatial correlations. Vis Res. 2015;108:41\u20138.","journal-title":"Vis Res"},{"key":"2382_CR26","doi-asserted-by":"crossref","unstructured":"Sabeti F, Lane J, Rohan EMF, Essex RW, McKone E, Maddess T.\u00a0Relationships between retinal structure and function and vision-related quality of life measures in advanced age-related macular degeneration.\u00a0Graefes Arch Clin Exp Ophthalmol.\u00a02021;259:3687\u201396.","DOI":"10.1007\/s00417-021-05296-9"},{"issue":"7","key":"2382_CR27","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1167\/iovs.08-3143","volume":"50","author":"HW van Dijk","year":"2009","unstructured":"van Dijk HW, Kok PH, Garvin M, et al. Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009;50(7):3404\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"2382_CR28","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/01.iae.0000244263.98642.61","volume":"26","author":"K Nitta","year":"2006","unstructured":"Nitta K, Saito Y, Kobayashi A, Sugiyama K. Influence of clinical factors on blue-on-yellow perimetry for diabetic patients without retinopathy: comparison with white-on-white perimetry. Retina. 2006;26(7):797\u2013802.","journal-title":"Retina"},{"key":"2382_CR29","first-page":"6934","volume":"56","author":"CF Carle","year":"2015","unstructured":"Carle CF, James AC, Kolic M, Essex RW, Maddess T. Blue multifocal pupillographic objective perimetry in glaucoma. Invest Ophth Vis Sci. 2015;56:6934\u2013403.","journal-title":"Invest Ophth Vis Sci"},{"issue":"211","key":"2382_CR30","first-page":"1","volume":"21","author":"EN Ali","year":"2021","unstructured":"Ali EN, Carle CF, Lueck CJ, Kolic M, Maddess T. Assessing migraine patients with multifocal pupillographic objective perimetry. BMC Neurol. 2021;21(211):1\u201312.","journal-title":"BMC Neurol"},{"issue":"5","key":"2382_CR31","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1755-3768.1994.tb07180.x","volume":"72","author":"M Henricsson","year":"1994","unstructured":"Henricsson M, Heijl A. Visual fields at different stages of diabetic retinopathy. Acta Ophthalmol. 1994;72(5):560\u20139.","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"2382_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3109\/07853899809029936","volume":"30","author":"A Verrotti","year":"1998","unstructured":"Verrotti A, Lobefalo L, Petitti MT, et al. Relationship between contrast sensitivity and metabolic control in diabetics with and without retinopathy. Ann Med. 1998;30(4):369\u201374.","journal-title":"Ann Med"},{"issue":"9","key":"2382_CR33","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1038\/eye.2009.184","volume":"23","author":"A Verma","year":"2009","unstructured":"Verma A, Rani PK, Raman R, et al. Is neuronal dysfunction an early sign of diabetic retinopathy? Microperimetry and spectral domain optical coherence tomography (SD-OCT) study in individuals with diabetes, but no diabetic retinopathy. Eye (Lond). 2009;23(9):1824\u201330.","journal-title":"Eye (Lond)"},{"issue":"2","key":"2382_CR34","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1167\/iovs.10-5931","volume":"52","author":"WW Harrison","year":"2011","unstructured":"Harrison WW, Bearse MA Jr, Ng JS, et al. Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes. Invest Ophthalmol Vis Sci. 2011;52(2):772\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"2382_CR35","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/eye.2017.27","volume":"31","author":"G Montesano","year":"2017","unstructured":"Montesano G, Gervasoni A, Ferri P, et al. Structure-function relationship in early diabetic retinopathy: a spatial correlation analysis with OCT and microperimetry. Eye (Lond). 2017;31(6):931\u20139.","journal-title":"Eye (Lond)"},{"key":"2382_CR36","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1038\/s41598-018-21196-1","volume":"8","author":"Y Rosli","year":"2018","unstructured":"Rosli Y, Carle CF, Ho Y, et al. Retinotopic effects of visual attention revealed by dichoptic multifocal pupillography. Sci Rep. 2018;8:2991.","journal-title":"Sci Rep"},{"key":"2382_CR37","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/OPX.0000000000000319","volume":"91","author":"F Sabeti","year":"2014","unstructured":"Sabeti F, Maddess T, Saikal A, et al. Multifocal pupillography in early age-related macular degeneration. Opt Vis Sci. 2014;91:904\u201315.","journal-title":"Opt Vis Sci"},{"issue":"5","key":"2382_CR38","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1136\/bjophthalmol-2011-300467","volume":"96","author":"GR Jackson","year":"2012","unstructured":"Jackson GR, Scott IU, Quillen DA, Walter LE, Gardner TW. Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy. Br J Ophthalmol. 2012;96(5):699\u2013703.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"2382_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10633-011-9298-6","volume":"123","author":"M Tyrberg","year":"2011","unstructured":"Tyrberg M, Lindblad U, Melander A, et al. Electrophysiological studies in newly onset type 2 diabetes without visible vascular retinopathy. Doc Ophthalmol. 2011;123(3):193\u20138.","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"2382_CR40","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1001\/archopht.1990.01070050070033","volume":"108","author":"S Juen","year":"1990","unstructured":"Juen S, Kieselbach GF. Electrophysiological changes in juvenile diabetics without retinopathy. Arch Ophthalmol. 1990;108(3):372\u20135.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"2382_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10633-004-8745-z","volume":"108","author":"ME Schneck","year":"2004","unstructured":"Schneck ME, Bearse MA Jr, Han Y, et al. Comparison of mfERG waveform components and implicit time measurement techniques for detecting functional change in early diabetic eye disease. Doc Ophthalmol. 2004;108(3):223\u201330.","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"2382_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10633-010-9245-y","volume":"121","author":"BE Wolff","year":"2010","unstructured":"Wolff BE, Bearse MA Jr, Schneck ME, Barez S, Adams AJ. Multifocal VEP (mfVEP) reveals abnormal neuronal delays in diabetes. Doc Ophthalmol. 2010;121(3):189\u201396.","journal-title":"Doc Ophthalmol"},{"key":"2382_CR43","volume-title":"World Glaucoma Congress. vol. ABSUB-824","author":"T Maddess","year":"2021","unstructured":"Maddess T, van Kleef JP, Kolic M, et al. Comparing macular and wide-field objective perimetry. In:  World Glaucoma Congress. vol. ABSUB-824; 2021."}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02382-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-022-02382-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02382-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T20:03:12Z","timestamp":1649966592000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-022-02382-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2382"],"URL":"https:\/\/doi.org\/10.1186\/s12886-022-02382-2","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,13]]},"assertion":[{"value":"22 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ACT Health and the Australian National University Human Research Ethics Committees and informed written consent was obtained from all subjects. All methods were carried out in accordance with relevant guidelines and regulations. The study was approved by the ACT Health and the Australian National University Human Research Ethics Committees, adhered to the tenets of the Declaration of Helsinki, and informed written consent was obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"T.M. Stock: EyeCo Pty Ltd., Royalties: Konan Medical USA, Patent: Konan Medical USA, Equipment: ColorDx and EyeKinetix.C.F.C Royalties: Konan Medical USA, Patent: Konan Medical USA,A.C.J Royalties: Konan Medical USA.Other Authors do not have any competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}